Girlich, C. and Schoelmerich, J. (2012) Topical Delivery of Steroids in Inflammatory Bowel Disease. CURRENT DRUG DELIVERY, 9 (4). pp. 345-349. ISSN 1567-2018
Full text not available from this repository. (Request a copy)Abstract
Crohn's disease (CD) and ulcerative colitis (UC) represent two similar but probably not uniform entities of inflammatory bowel disease (IBD). Since up to now no curative treatment is available the therapeutic goal in active IBD is elimination or at least alleviation of symptoms and maintenance of remission. Glucocorticoids have been successfully used in the treatment of symptoms and inflammation. Due to the minor systemic side effects a topical drug delivery targeting the active substances directly to the inflamed sites would be the favorable administration. In this review the use of topical corticosteroids is discussed, based on a short description of their pharmacological properties.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | ACTIVE CROHNS-DISEASE; DISTAL ULCERATIVE-COLITIS; ILEAL RELEASE CAPSULES; BECLOMETHASONE DIPROPIONATE; ORAL BUDESONIDE; 5-AMINOSALICYLIC ACID; MAINTENANCE TREATMENT; RETENTION ENEMAS; CONTROLLED-TRIAL; DOUBLE-BLIND; Steroids; inflammatory bowel disease |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin I |
| Depositing User: | Petra Gürster |
| Date Deposited: | 18 May 2020 06:57 |
| Last Modified: | 18 May 2020 06:57 |
| URI: | https://pred.uni-regensburg.de/id/eprint/18466 |
Actions (login required)
 |
View Item |
